Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient’s diseased aortic valve. GlobalData uses proprietary data and analytics to provide a comprehensive report on the transcatheter aortic valve replacement devices market, including market shares of different players within South Africa. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the transcatheter aortic valve replacement market in South Africa was Edwards Lifesciences followed by Medtronic and Boston Scientific.
The procedure is largely performed transfemorally (through the groin) but can also be performed via alternative pathways including the transapical, transaortic, transcarotid, transsubclavian and transcaval approaches.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the transcatheter aortic valve replacement devices market within South Africa was expected to be over $7m in 2022.
For the latest complete market share analysis of transcatheter aortic valve replacement device market in South Africa, buy the report here.